Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Octopus BiosafetySTU:OCR 1 Cyclically Adjusted PS Ratio is 3.33 as of Jul. 24, 2026, which is 29% below its 10-year median of 4.68. GuruFocus rates STU:OCR with a GF Score™ of 1/100 and a GF Value™ of €0.05. The stock has 2 warning signs investors should review. Among 1,976 Hardware companies, Octopus Biosafety ranks worse than 79.45% on this metric.
The historical rank and industry rank for Octopus Biosafety's Cyclically Adjusted PS Ratio or its related term are showing as below:
STU:OCR'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.5 Med: 4.68 Max: 12.5
Current: 4.53
During the past 10 years, Octopus Biosafety's highest Cyclically Adjusted PS Ratio was 12.50. The lowest was 2.50. And the median was 4.68.
STU:OCR's Cyclically Adjusted PS Ratio is ranked worse than 79.45% of 1976
companies
in the Hardware industry
Industry Median: 1.37
vs STU:OCR: 4.53
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Octopus Biosafety's adjusted revenue per share data of for the fiscal year that ended in Dec24 was €0.004. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €0.03 for the trailing ten years ended in Dec24.
Shiller PE for Stocks: The True Measure of Stock Valuation
Octopus Biosafety (STU:OCR) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Octopus Biosafety Cyclically Adjusted PS Ratio Related Terms
Octopus Biosafety Cyclically Adjusted PS Ratio Historical Data
* Premium members only.
The historical data trend for Octopus Biosafety's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Octopus Biosafety Cyclically Adjusted PS Ratio Chart
STU:OCR vs SNDK, DELL, STX: Cyclically Adjusted PS Ratio Comparison
For the Computer Hardware subindustry, Octopus Biosafety's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Octopus Biosafety Cyclically Adjusted PS Ratio vs Hardware Industry
For the Hardware industry and Technology sector, Octopus Biosafety's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Octopus Biosafety's Cyclically Adjusted PS Ratio falls into.
Octopus Biosafety Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
Octopus Biosafety's Cyclically Adjusted PS Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 3.33 mean?
Octopus Biosafety (STU:OCR) has a Cyclically Adjusted PS Ratio of 3.33 as of Jul. 24, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Octopus Biosafety and its competitors. This is 29% below median its historical median of 4.68. Over the past decade, Octopus Biosafety's Cyclically Adjusted PS Ratio has ranged from 2.50 to 12.50. According to the industry distribution chart, Octopus Biosafety ranks #1570 out of 1976 companies in the Hardware industry, placing it in the top 79.5%.
Is Octopus Biosafety's Cyclically Adjusted PS Ratio too high?
Octopus Biosafety's current Cyclically Adjusted PS Ratio of 3.33 is 29% below median its 10-year median of 4.68. Over the past 10 years, this metric has ranged from a low of 2.50 to a high of 12.50. The Hardware industry median Cyclically Adjusted PS Ratio is 1.37. Octopus Biosafety's value of 3.33 is 143.1% above this industry median. Based on the distribution chart, Octopus Biosafety ranks #1570 out of 1976 companies in the Hardware industry, which is in the bottom quartile relative to peers. Overall, Octopus Biosafety has a GF Score™ of 1/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's Cyclically Adjusted PS Ratio compare to SNDK and DELL?
According to the Hardware industry distribution chart, Octopus Biosafety ranks #1570 out of 1976 companies for Cyclically Adjusted PS Ratio. This places Octopus Biosafety in the lower half of its industry. The industry median Cyclically Adjusted PS Ratio is 1.37. Octopus Biosafety's value of 3.33 is 143.1% above this benchmark. Historically, Octopus Biosafety's own Cyclically Adjusted PS Ratio has ranged from 2.50 to 12.50 over the past decade. While the company's 10-year median is 4.68 vs. the industry median of 1.37, Octopus Biosafety has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Hardware company?
The median Cyclically Adjusted PS Ratio among Hardware companies is 1.37, based on 1,976 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Octopus Biosafety's current Cyclically Adjusted PS Ratio of 3.33 is 143.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Octopus Biosafety and its competitors. For the Hardware industry, the median Cyclically Adjusted PS Ratio is 1.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Octopus Biosafety's current Cyclically Adjusted PS Ratio is 3.33, which is 29% below median its own 10-year median of 4.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current Cyclically Adjusted PS Ratio of 3.33. The stock's GF Value™ is €0.05, compared to a current price of €0.10 — trading 100% above its estimated fair value. The current Cyclically Adjusted PS Ratio is 3.33, which is 29% below median its 10-year median of 4.68 and 143.1% above the Hardware industry median of 1.37. Octopus Biosafety's overall GF Score™ is 1/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current Cyclically Adjusted PS Ratio is 3.33 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Octopus Biosafety (STU:OCR) Overvalued in 2026?
Based on GuruFocus' analysis, Octopus Biosafety stock appears to be overvalued.
The current stock price of €0.10 is trading 100% above its estimated GF Value™ of €0.05.
Key valuation signals for STU:OCR:
Cyclically Adjusted PS Ratio: 3.33 (29% below median its 10-year median of 4.68)
GF Value™: €0.05 vs. price of €0.10 (100% above fair value)
Industry Position: 143.1% above the Hardware median (#1570 of 1976)
No single metric tells the full story. See the STU:OCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
1GF Score
Get the complete analysis for STU:OCR
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:OCR has been successfully added to your 
